000 01356 a2200421 4500
005 20250511214605.0
264 0 _c19901004
008 199010s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/0140-6736(90)93401-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThompson, A J
245 0 0 _aNeurological deterioration in young adults with phenylketonuria.
_h[electronic resource]
260 _bLancet (London, England)
_cSep 1990
300 _a602-5 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBrain
_xpathology
650 0 4 _aBrain Diseases
_xetiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aPatient Compliance
650 0 4 _aPhenylalanine
_xadministration & dosage
650 0 4 _aPhenylketonurias
_xcomplications
650 0 4 _aRetrospective Studies
650 0 4 _aTime Factors
700 1 _aSmith, I
700 1 _aBrenton, D
700 1 _aYoul, B D
700 1 _aRylance, G
700 1 _aDavidson, D C
700 1 _aKendall, B
700 1 _aLees, A J
773 0 _tLancet (London, England)
_gvol. 336
_gno. 8715
_gp. 602-5
856 4 0 _uhttps://doi.org/10.1016/0140-6736(90)93401-a
_zAvailable from publisher's website
999 _c1981572
_d1981572